You are here

Risk of Heart Failure with the Use of Thiazolidinediones within a Medicaid Population

Fadia T. Shaya, PhD, MPH, James Y. Shin, PharmD, C. Daniel Mullins, PhD, Antoine C. El Khoury, PhD, and Howard Garber, MD, MPH
PDF version: 
Analyzing patients’ prescription and medical claims from a managed care organization, the authors evaluate the risk of heart failure after TZD therapy.